Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2009
11/18/2009CN101579422A Measuring method of high-performance liquid chromatogram fingerprint of jiangzhining
11/18/2009CN101579399A Pharmaceutical composition for reducing blood sugar and blood fat, and curing diabetes
11/18/2009CN101579398A Pharmaceutical composition for lowering blood sugar and blood fat as well as for treating diabetes
11/18/2009CN101579397A Composition for treating diabetes and preparation method thereof
11/18/2009CN101579382A Medicinal composition for treating diabetes mellitus and preparation method thereof
11/18/2009CN101579380A Medicinal dripping pill for treating diabetes mellitus
11/18/2009CN101579374A Medicine composition for reducing blood fat
11/18/2009CN101579373A Medicine composition for reducing blood fat
11/18/2009CN101579372A Medicine composition for reducing blood fat
11/18/2009CN101579371A Medicine composition for reducing blood fat
11/18/2009CN101579351A Application of ACL on sieving drugs for preventing obesity-related metabolic disturbance diseases
11/18/2009CN101579344A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009CN101579343A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009CN101579332A Pharmaceutical composition for treating cardiovascular disease and application thereof
11/18/2009CN101579331A Application of alpha-ketoglutarate magnesium in preparing medicament for resisting heart and cerebral ischemia
11/18/2009CN101579325A Metformin hydrochloride controlled-release tablet and preparation method thereof
11/18/2009CN101579322A Method for preparing dimethyldiguanide tablet
11/18/2009CN101579321A Preparation process for glimepiride tablet
11/18/2009CN101579291A Resveratrol phospholipid composite nano-emulsion and preparation method and application thereof
11/18/2009CN101579126A Special meal nutritional food used for rehabilitation after partum and artificial abortion
11/18/2009CN101579121A Nutritional food with hpyerglycemic function and preparation method thereof
11/18/2009CN101579120A Nutritional food with weight-losing function and preparation method thereof
11/18/2009CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
11/18/2009CN100560585C New benzimidazole derivative
11/18/2009CN100560582C Piperidinopyrazoles compound and its preparation method and application
11/18/2009CN100560112C A composition used for regulating blood-fat and its preparation method
11/18/2009CN100560095C Compound preparation containing extractive of almond and extractive of ginkgo leaf
11/18/2009CN100560085C Chinese herbal medicine and its use
11/18/2009CN100560082C Medical application of fruit extraction of miracle fruit
11/18/2009CN100560081C Method for extracting flavonoids from the waxberry core
11/18/2009CN100560076C Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions
11/18/2009CN100560075C Medicine for modulating lipid metabolism
11/18/2009CN100560074C External patch containing estrogen and/or progestogen
11/18/2009CN100560070C Imidazol derivatives having affinity for alpha 2 receptors activity
11/18/2009CN100560069C Mitiglinide calcium formulation and its detection method
11/18/2009CN100560060C Nano-grade medicine microball and preparation process thereof
11/17/2009US7619097 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus
11/17/2009US7619065 Cystine-knot fold protein
11/17/2009US7619001 Utilization of dialkylfumarates
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009US7618955 Association of an antithrombotic and aspirin
11/17/2009US7618951 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
11/17/2009US7618818 Method for detecting leptin receptor ligands
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618648 treating, preventing obesity or being overweight, administering whey protein hydrolyzate, to induce the cellular release of glucagon-like-peptides and cholecystokinins
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
11/17/2009CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009CA2411368C Therapeutic combinations of fatty acids
11/17/2009CA2397450C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2369997C Compositions and methods for treating amyloidosis
11/17/2009CA2339090C Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
11/17/2009CA2336822C Method of treatment and pharmaceutical composition
11/17/2009CA2262600C Stanol composition and the use thereof
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/17/2009CA2254394C Method and composition for the treatment and prevention of hyperuricemia
11/12/2009WO2009137844A2 Pancreatic endocrine progenitor cells derived from pluripotent stem cells
11/12/2009WO2009137795A2 Methods for treating endoplasmic reticulum (er) stress disorders
11/12/2009WO2009137201A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/12/2009WO2009136814A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136813A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
11/12/2009WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases
11/12/2009WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009WO2009136587A1 Anti-fatigue composition
11/12/2009WO2009136396A2 Sulfobetaines for therapy
11/12/2009WO2009136219A1 Compositions comprising galactomannan and a process thereof
11/12/2009WO2009135960A1 Carbohydrate mixture and the use thereof for preparing a product for oral or enteral nutrition
11/12/2009WO2009135959A1 Food product for enterally or orally feeding diabetic patients
11/12/2009WO2009135925A1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
11/12/2009WO2009135583A1 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
11/12/2009WO2009135581A2 Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/12/2009WO2009135580A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
11/12/2009WO2009135526A1 Alpha-mercapto-amides
11/12/2009WO2009135353A1 Use of prunus mume extracts
11/12/2009WO2009135352A1 A plum tree extract, a method for preparing the plum tree extract and use thereof
11/12/2009WO2009135351A1 The use of the extract of prunus mume for preparation of compositions
11/12/2009WO2009073067A3 Compositions and methods for ameliorating hyperlipidemia
11/12/2009WO2009071691A3 Oxindole derivatives and the use thereof as a medication
11/12/2009WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009WO2008139261A9 Omega-3 lipid compound
11/12/2009US20090281170 Polynucleotide therapy
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009US20090281143 Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
11/12/2009US20090281142 Thiazole derivative
11/12/2009US20090281134 Use of ibogamine congeners for treating obesity
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281121 SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE AND 8-PIPERIDINYL-2-PYRIMIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE DERIVATIVES
11/12/2009US20090281116 Pyrrole derivatives, preparation thereof and therapeutic use thereof
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 1298